DANRSV Effect of RSV Vaccine on Heart Failure | JACC | ESC.25

JACC is proud to publish this video interview with Associate Editor Jason H. Wasfy, MD, MPhil, FACC and Kristoffer Grundtvig Skaarup, MD. In their talk about this paper presented at ESC and simultaneously published in JACC, they discuss this exploratory prespecified analysis of the DAN-RSV Trial. RSVpreF vaccination was associated with reduced risks of RSV-related, respiratory, and cardio-respiratory hospitalizations, with no appreciable differences between individuals with and without HF and across HF subgroups.